Baseline evaluation with a psychiatrist
OtherBaseline data and questionnaires are established.
NCT Number: NCT02664701
The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
CHU de Clermont Ferrand - Hôpital Gabriel-Montpied, Clermont-Ferrand, France
The secondary objectives of this study are to assess the efficacy of CBGT on:
A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time,
B. long-term changes in suicidal ideation,
C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Baseline data and questionnaires are established.
6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks
6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks
Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.
Time frame: 12 months
Time frame: baseline
Time frame: in the 10 days after the end of psychotherapy
Time frame: 3 months
Time frame: 6 months
Time frame: 9 months
Time frame: 12 months
Time frame: in the 10 days after the end of psychotherapy
Time frame: 3 months
Time frame: 6 months
Time frame: 9 months
Time frame: 12 months
Time frame: in the 10 days after the end of psychotherapy
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
Time frame: 3 months
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
Time frame: 6 months
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
Time frame: 9 months
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
Time frame: 12 months
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
Time frame: Baseline
Time frame: in the 10 days after the end of psychotherapy
Time frame: 3 months
Time frame: 6 months
Time frame: 9 months
Time frame: 12 months
Time frame: Baseline
Time frame: in the 10 days after the end of psychotherapy
Time frame: 3 months
Time frame: 6 months
Time frame: 9 months
Time frame: 12 months
Time frame: Baseline
Time frame: in the 10 days after the end of psychotherapy
Time frame: 3 months
Time frame: 6 months
Time frame: 9 months
Time frame: 12 months
Time frame: in the 10 days after the end of psychotherapy
Time frame: 3 months
Time frame: 6 months
Time frame: 9 months
Time frame: 12 months
Centre Hospitalier Universitaire de Nīmes
Other
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial
Acronym: G-PACTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06233747
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05256940
Behavior, Behavioral Symptoms
Canandaigua, New York, United States
View Trial DetailsNCT05401838
Anxiety, Anxiety Disorders
Portsmouth, Virginia, United States
View Trial DetailsNCT06322199
Behavior, Behavioral Symptoms
Lausanne, Switzerland
View Trial Details